Specialized pancreatic tumor-infiltrating dendritic cells (CD11b+CD103−) induce tumor-promoting Tr1-like phenotype of CD4+ T cells that, among others, show high expression of CD39 and CD73, and promote tolerance to PDAC and resistance to immunotherapy [159]. This evidence concerns the gene ENTPD1 and neoplasm.